CDEK
← All organizations

Abraxis

For profitContributed to NME

Also known as: ABRAXIS BIOSCIENCE | ABRAXIS PHARM | APP PHARMS

Phase 1Phase 2Phase 3Phase 4

First marketed drug

Jan 1, 2007

Last known activity

May 28, 2002

Acquired by Celgene → Bristol-Myers Squibb on Jan 1, 2010

Timeline

1980s

  1. May 5, 1987

    cupric sulfate pentahydrate— NDA Organization

  2. Apr 1, 1988

    diazepam— Marketing Organization

  3. Dec 22, 1989

    clindamycin— NDA Secondary Org

2000s

  1. Jan 1, 2007

    Abraxis— Founded

  2. Jun 1, 2007

    American Bioscience— Acquired

  3. Jun 1, 2007

    American Pharmaceutical Partners— Acquired

2010s

  1. Jan 1, 2010

    Celgene— Acquired By

  2. Jan 3, 2019

    Bristol-Myers Squibb— Now

Marketed drugs (77)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Details

Founded
Los Angeles, CA, US Jan 1, 2007
Last known activity
May 28, 2002